| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 6.40 | 3.81 | 9.51 | 6.63 |
| Receivables | 0.01 | 0.00 | 0.01 | 0.01 |
| Inventory | 1.18 | 1.05 | 1.40 | 1.19 |
| Other | — | — | — | — |
| 8.05 | 5.34 | 11.60 | 8.67 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 0.90 | 0.75 | 0.56 | 0.46 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 2.05 | 2.03 | 1.93 | 1.78 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3.21 | 3.35 | — | — |
—
|
| ’25 | 2.59 | 2.85 | 2.92 | 3.07 |
11.43
|
| ’24 | 2.61 | 2.34 | 2.71 | 2.25 |
9.90
|
| ’23 | 2.81 | 2.33 | 2.37 | 2.43 |
9.93
|
| ’22 | 3.65 | 3.37 | 2.75 | 2.15 |
11.92
|
| ’22 | — | — | — | — |
11.92
|
| ’21 | 2.44 | 2.78 | 2.38 | 2.42 |
10.02
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.65) | 0.08 | — | — |
—
|
| ’25 | (1.65) | (1.01) | (0.76) | (1.64) |
(5.06)
|
| ’24 | (1.09) | (1.53) | (0.64) | (0.99) |
(4.25)
|
| ’23 | (1.38) | (1.81) | (0.40) | (0.72) |
(4.32)
|
| ’22 | 0.29 | (0.75) | (1.46) | (1.70) |
(3.61)
|
| ’22 | — | — | — | — |
(3.61)
|
| ’21 | (1.00) | (0.77) | (1.52) | (2.62) |
(5.91)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.95) | (0.34) | — | — |
—
|
| ’25 | (7.82) | (9.44) | (1.19) | (1.97) |
(6.48)
|
| ’24 | (1.26) | (1.93) | (1.13) | (1.40) |
(5.72)
|
| ’23 | (1.53) | (2.21) | (0.89) | (1.06) |
(5.69)
|
| ’22 | 0.26 | (1.16) | (1.74) | (2.28) |
(4.92)
|
| ’22 | — | — | — | — |
(3.61)
|
| ’21 | (1.00) | (0.77) | (1.52) | (2.62) |
(5.91)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1.68) | (1.81) | — | — |
—
|
| ’25 | (92.31) | 0.00 | (2.21) | (1.96) |
(13.06)
|
| ’24 | (16.35k) | (18.46k) | (3.85k) | — |
(11.27k)
|
| ’23 | (36.92k) | (35.19k) | (21.15k) | (133.27k) |
(224.23k)
|
| ’22 | (53.85k) | (50.00k) | (88.46k) | (100.00k) |
(292.31k)
|
| ’22 | — | — | — | — |
(15.15)
|
| ’21 | (461.54k) | (76.92k) | (46.15k) | (0.69) |
(857.69k)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 138,750.00 | 15,937.50 | 1,057.50 | 0.63 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,676,250.00 | 198,750.00 | 24,187.50 | 1,314.75 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 27 | 27 | 32 | 35 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.37 | 0.31 | 0.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.92 | 9.93 | 9.90 | 11.43 | ‡‡‡‡‡ | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.52% | 67.07% | 66.81% | 66.79% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.79) | (14.86) | (8.99) | (7.45) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (56.95%) | (149.66%) | (90.83%) | (65.23%) | ‡‡‡ | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.92) | (14.55) | (9.00) | (7.47) | ‡‡‡‡‡ | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.82 | 8.76 | 1.61 | 2.10 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.89 | 99,296.00 | 12,377.50 | 19.21 | ‡‡‡‡‡ | — | — |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (15.15) | (224,230.80) | (11,269.23) | (13.06) | ‡‡‡‡‡ | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.54) | (43,155.00) | (5,318.50) | (8.51) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | (13,734.00) | (1,825.75) | (2.39) | ‡‡‡ | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.54) | (56,889.00) | (7,144.25) | (10.90) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.60 | 131,052.00 | 12,981.50 | 27.37 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.48 | 0.00 | 0.00 | 0.59 | ‡‡‡‡‡ | — | — |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡‡‡ | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 793,042.78 | 0.20 | 0.09 | 0.04 | ‡‡‡ | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 304,879.09 | 0.16 | 0.09 | 0.03 | ‡‡‡ | — | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 793,041.58 | (0.43) | (0.28) | (0.78) | ‡‡‡‡ | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,338,555.67) | 0.75 | 0.48 | 0.44 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.61) | (4.32) | (4.25) | (5.06) | ‡‡‡ | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | — | — | (1.31) | (1.37) | (1.46) | (1.42) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (3.61) | (5.69) | (5.72) | (6.48) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.12 | 6.00 | 3.31 | 9.67 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.19 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.85) | (6.40) | (3.81) | (9.51) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.79 | 13.11 | 10.39 | 16.28 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (26.01%) | (73.99%) | (59.57%) | (44.99%) | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | (142.84%) | (72.88%) | (72.89%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (31.18%) | (94.93%) | (83.14%) | (60.78%) | — | — | — |
ROE
|
LogicMark (LGMK), a micro-cap maker of medical alert devices and monitoring tech, has a rocky history of revenue peaks in 2018-2019 followed by sharp declines to $9.9 million in 2024, driven by COVID disruptions and competition from giants like Philips. While gross margins hit 70% at their best, persistent losses topping $100 million cumulatively, negative cash flows, and aggressive dilutions via reverse splits have crushed shareholder value, leaving metrics like ROE at -83% and book value per share down 90%. A bright spot is slashing debt to near zero, creating a net cash position, but ongoing burns signal survival mode over growth.
Valuation looks dirt-cheap at PS and PB ratios of 0.09, with analysts dreaming up 225,000% upside on modest revenue forecasts to $11.9 million by 2026—yet profitability remains elusive, with projected losses and zero insider buying screaming caution. Share count volatility and Nasdaq battles highlight the penny-stock perils in this reimbursement-sensitive sector.
For risk-tolerant speculators eyeing lottery odds amid aging demographics, LGMK tempts at these depths, but conservatives should watch for insider buys or profit turns before diving in—plenty more details in the full analysis to weigh the gamble.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.